↓ Skip to main content

Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis.

Overview of attention for article published in Stem Cell Research & Therapy, September 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis.
Published in
Stem Cell Research & Therapy, September 2014
DOI 10.1186/scrt497
Pubmed ID
Authors

Michelle M Duffy, Matthew D Griffin

Abstract

Systemic administration of mesenchymal stem (stromal) cells (MSCs) has shown benefit in a range of experimental models of acute kidney injury, although the reported mechanisms of action and requirement for MSC localization to the kidney have varied. Geng and colleagues now demonstrate that a single intravenous infusion of MSCs given 6 hours after induction of acute muscle necrosis (rhabdomyolysis) robustly ameliorates the resulting acute kidney injury and promotes early intra-renal accumulation of CD206+ (M2) macrophages. The benefit occurred in the absence of MSC localization to the kidney and could be reproduced by adoptive transfer of ex vivo-programmed M2 macrophages.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Russia 1 10%
Unknown 9 90%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 40%
Professor 3 30%
Other 1 10%
Student > Master 1 10%
Researcher 1 10%
Other 0 0%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 30%
Medicine and Dentistry 2 20%
Immunology and Microbiology 1 10%
Computer Science 1 10%
Neuroscience 1 10%
Other 0 0%
Unknown 2 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2015.
All research outputs
#2,537,349
of 4,777,873 outputs
Outputs from Stem Cell Research & Therapy
#247
of 413 outputs
Outputs of similar age
#84,115
of 151,946 outputs
Outputs of similar age from Stem Cell Research & Therapy
#28
of 33 outputs
Altmetric has tracked 4,777,873 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 413 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 151,946 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.